These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18281200)

  • 1. 123I-ADAM SPECT imaging of serotonin transporter binding in patients with night eating syndrome: a preliminary report.
    Lundgren JD; Newberg AB; Allison KC; Wintering NA; Ploessl K; Stunkard AJ
    Psychiatry Res; 2008 Apr; 162(3):214-20. PubMed ID: 18281200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome.
    Lundgren JD; Amsterdam J; Newberg A; Allison KC; Wintering N; Stunkard AJ
    Eat Weight Disord; 2009 Mar; 14(1):45-50. PubMed ID: 19367140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.
    Erlandsson K; Sivananthan T; Lui D; Spezzi A; Townsend CE; Mu S; Lucas R; Warrington S; Ell PJ
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the Serotonin Transporter Availability Among Male Cigarette Smokers: A SPECT Study With [123I] ADAM.
    Zhao RJ; Lin SH; Lee LT; Lee IH; Chen PS; Chen KC; Yang YK
    J Addict Med; 2016; 10(2):89-92. PubMed ID: 26742023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biobehavioural model of the night eating syndrome.
    Stunkard AJ; Allison KC; Lundgren JD; O'Reardon JP
    Obes Rev; 2009 Nov; 10 Suppl 2():69-77. PubMed ID: 19849804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No seasonal variation in human midbrain serotonin transporter availability in Taiwan.
    Cheng YS; Chen KC; Yang YK; Chen PS; Yeh TL; Lee IH; Chang YH; Liao MH
    Psychiatry Res; 2011 Dec; 194(3):396-399. PubMed ID: 22041533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.
    Oya S; Choi SR; Hou C; Mu M; Kung MP; Acton PD; Siciliano M; Kung HF
    Nucl Med Biol; 2000 Apr; 27(3):249-54. PubMed ID: 10832081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
    Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
    Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM.
    Yang YK; Yao WJ; Yeh TL; Lee IH; Chen KC; Lu RB
    Psychiatry Res; 2007 Apr; 154(3):281-4. PubMed ID: 17349781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.
    Sacher J; Asenbaum S; Klein N; Geiss-Granadia T; Mossaheb N; Poetzi C; Attarbaschi T; Lanzenberger R; Spindelegger C; Rabas A; Heinze G; Dudczak R; Kasper S; Tauscher J
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):211-8. PubMed ID: 16487452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.
    Catafau AM; Pérez V; Penengo MM; Bullich S; Danús M; Puigdemont D; Pascual JC; Corripio I; Llop J; Perich J; Alvarez E
    J Nucl Med; 2005 Aug; 46(8):1301-9. PubMed ID: 16085586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects.
    Lin KJ; Liu CY; Wey SP; Hsiao IT; Wu J; Fu YK; Yen TC
    Nucl Med Biol; 2006 Feb; 33(2):193-202. PubMed ID: 16546673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
    Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
    J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain and platelet serotonin transporter in humans-correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets.
    Uebelhack R; Franke L; Herold N; Plotkin M; Amthauer H; Felix R
    Neurosci Lett; 2006 Oct; 406(3):153-8. PubMed ID: 16934400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography.
    Lin KJ; Yen TC; Wey SP; Hwang JJ; Ye XX; Tzen KY; Fu YK; Chen JC
    J Nucl Med; 2004 Apr; 45(4):673-81. PubMed ID: 15073265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
    Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low brain serotonin transporter binding in major depressive disorder.
    Newberg AB; Amsterdam JD; Wintering N; Shults J
    Psychiatry Res; 2012 May; 202(2):161-7. PubMed ID: 22698760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123) I]-ADAM SPECT.
    Amsterdam JD; Newberg AB; Newman CF; Shults J; Wintering N; Soeller I
    J Neuroimaging; 2013 Oct; 23(4):469-76. PubMed ID: 23751132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.